1. Home
  2. STOK vs LILAK Comparison

STOK vs LILAK Comparison

Compare STOK & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.40

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Latin America Ltd. Class C

LILAK

Liberty Latin America Ltd. Class C

HOLD

Current Price

$8.08

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
LILAK
Founded
2014
2017
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
STOK
LILAK
Price
$32.40
$8.08
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$34.50
$8.20
AVG Volume (30 Days)
685.0K
949.9K
Earning Date
03-17-2026
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.68
N/A
Revenue
$205,632,000.00
$4,433,000,000.00
Revenue This Year
$430.24
$1.37
Revenue Next Year
N/A
N/A
P/E Ratio
$44.52
N/A
Revenue Growth
1128.17
N/A
52 Week Low
$5.35
$4.23
52 Week High
$38.69
$9.13

Technical Indicators

Market Signals
Indicator
STOK
LILAK
Relative Strength Index (RSI) 57.24 56.45
Support Level $30.33 $7.67
Resistance Level $34.47 $8.11
Average True Range (ATR) 2.02 0.31
MACD 0.32 0.06
Stochastic Oscillator 84.32 77.07

Price Performance

Historical Comparison
STOK
LILAK

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: